Thyrocare Q2 Profit Slips 68% YoY To ₹15 Cr Due To ₹45 Cr Exceptional Expense

PharmEasy-backed Thyrocare’s net profit for the September quarter (Q2 FY27) slumped 68.2% year-on-year (YoY) to ₹15.2 Cr from ₹47.8 Cr…

india

Sources